Loading organizations...
§ Private Profile · Singapore, Central Region, Singapore
mRNA platform company developing vaccines and therapeutics for diseases.
RVAC Medicines has raised $140.0M across 1 funding round.
RVAC Medicines has raised $140.0M in total across 1 funding round.
RVAC Medicines has raised $140.0M across 1 funding round. Most recently, it raised $140.0M Series B in April 2022.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Apr 27, 2022 | $140M Series B | WEI FU | Swee Yeok Chu, PBM, Suhhong HUR, Pavilion Capital | Announced |
RVAC Medicines has raised $140.0M in total across 1 funding round.
RVAC Medicines's investors include Wei Fu, Swee Yeok CHU, PBM, Suhhong Hur, Pavilion Capital.